ArticleScience advances2026
Structurally engineered ultrasoft PEDOT:PSS fiber microelectrodes with enhanced electrochemical performance for neural interfaces.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stable and reliable neural interfacing is essential for the diagnosis and treatment of chronic neurological disorders. Flexible neural probes are particularly important for this purpose, as they minimize tissue damage and inflammatory responses while maintaining stable electrode-tissue coupling; however, achieving both high electrical performance and tissue-like mechanics remains challenging. Here, we present a poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) fiber microelectrode (PFME), an all-organic neural probe capable of recording single-neuron activities with potential for long-term interfacing. The PFME is entirely composed of organic components and fabricated without thermal processing. In addition, the posttreatment process enables to selectively remove PSS binder networks while promoting PEDOT chain alignment to optimize mechanical compliance and electrochemical performance. In vivo, the PFME enables stable single-unit recordings from the mouse hippocampus. Histological analysis after 1 week of implantation reveals minimal glial activation comparable to that elicited by a conventional probe. This structurally engineered PFME establishes a pathway to achieve minimally invasive neural interfacing platforms for chronic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.